Everolimus-associated Alveolar Hemorrage Relapse After Drug Discontinuation in a Kidney Transplant Recipient

Lopez P, Kohler S, Dimri S . Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature. J Transplant. 2015; 2014:305931. PMC: 4281397. DOI: 10.1155/2014/305931. View

Almeida F, Amorim S, Sarmento A, Santos L . Life-Threatening Everolimus-Associated Pneumonitis: A Case Report and a Review of the Literature. Transplant Proc. 2018; 50(3):933-938. DOI: 10.1016/j.transproceed.2017.12.003. View

Mella A, Messina M, Ranghino A, Solidoro P, Tabbia G, Segoloni G . Pulmonary toxicity in a renal transplant recipient treated with amiodarone and everolimus: a case of hypothetical synergy and a proposal for a screening protocol. Case Rep Nephrol Urol. 2014; 4(1):75-81. PMC: 4025156. DOI: 10.1159/000362361. View